Evidence map›Paper›PMID 29406429›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2018

Mobile Health Intervention to Reduce HIV Transmission: A Randomized Trial of Behaviorally Enhanced HIV Treatment as Prevention (B-TasP).

Seth C Kalichman, Chauncey Cherry, Moira O Kalichman, Lisa A Eaton, James J Kohler, Catherine Montero, Raymond F Schinazi

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Leveraging mHealth for the Treatment and Management of PLHIV.Risk management and healthcare policy · 2023
    Article
  15. Review
  16. Review
  17. Article
  18. Journal of health care for the poor and underserved · 2021
    Article
  19. Sexually transmitted infections among women living with HIV in a Brazilian city.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Seth C KalichmanInstitute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, CT.
Chauncey CherryInstitute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, CT.
Moira O KalichmanInstitute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, CT.
Lisa A EatonInstitute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, CT.
James J KohlerDepartment of Pediatrics, Center for AIDS Research, Emory University School of Medicine, Atlanta, GA.
Catherine MonteroDepartment of Pediatrics, Center for AIDS Research, Emory University School of Medicine, Atlanta, GA.
Raymond F SchinaziDepartment of Pediatrics, Center for AIDS Research, Emory University School of Medicine, Atlanta, GA.
University of Connecticut · US

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Behavioral Intervention to Enhance HIV Test/TreatR01DA033067 · NIDA · UNIVERSITY OF CONNECTICUT STORRS · PI KALICHMAN, SETH C · 2012 to 2016
$3.3M
NIAID NIH HHS P30 AI050409NIDA NIH HHS R01 DA033067
6 · The paper itself

Abstract

objectivesWe conducted a randomized clinical trial to test a mobile health behavioral intervention designed to enhance HIV treatment as prevention (B-TasP) by simultaneously increasing combination antiretroviral therapies (cART) adherence and improving the sexual health of people living with HIV.

methodsA cohort of sexually active men (n = 383) and women (n = 117) living with HIV were enrolled. Participants were baseline assessed and randomized to either (1) B-TasP adherence and sexual health intervention or (2) general health control intervention. Outcome measures included HIV RNA viral load, cART adherence monitored by unannounced pill counts, indicators of genital tract inflammation, and sexual behaviors assessed over 12 months.

resultsEighty-six percent of the cohort was retained for 12-month follow-up. The B-TasP intervention demonstrated significantly lower HIV RNA, OR = 0.56, P = 0.01, greater cART adherence, Wald χ = 33.9, P = 0.01, and fewer indicators of genital tract inflammation, Wald χ = 9.36, P = 0.05, over the follow-up period. Changes in sexual behavior varied, with the B-TasP intervention showing lower rates of substance use in sexual contexts, but higher rates of condomless sex with non-HIV positive partners occurred in the context of significantly greater beliefs that cART reduces HIV transmission.

conclusionsTheory-based mobile health behavioral interventions can simultaneously improve cART adherence and sexual health in people living with HIV. Programs aimed to eliminate HIV transmission by reducing HIV infectiousness should be bundled with behavioral interventions to maximize their impact and increase their chances of success.

Indexed as

AdultBehavior TherapyCell PhoneCohort StudiesFemaleFollow-Up StudiesGeorgiaHealth Knowledge, Attitudes, PracticeHIVHIV InfectionsHumansInflammationMaleRisk Reduction BehaviorRNA, ViralSexual BehaviorRNA, Viral

Identifiers

PMID29406429
PMCPMC5889341
OpenAlexW2790614549

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.